Back to results
US 2020/0206366 A1Published application
Echolucent implants
AssigneeIncept, LLC
InventorsPatrick Campbell, Amarpreet S. Sawhney
Life of this patent
Estimating the term…
Abstract
Echolucent implantable compositions are described. Applications include materials for delivering of therapeutic agents to a tissue at a placement site.
Claims20
A pharmaceutically acceptable implant composition comprising:
- a collection of covalently-crosslinked hydrolytically biodegradable hydrogel particles, a therapeutic agent, and an osmotic agent, wherein the pharmaceutically acceptable implant composition is echolucent.
Dependencies are inferred from the claim text.